Back to search
FDAFDA · Food and drugs·Recall number D-0023-2026

Hydromorphone HCL PF, 10mg/50 mL (0.2mg/mL) in NACL, Injection for IV use, 50 mL Syringe, STAQ Pharma Inc., 14135 E 42nd Ave, Denver, Colorado, NDC 73177-0104-05.

Published October 22, 2025 · Recall initiated: October 9, 2025

Summary

FDA records drug Class III recall D-0023-2026, published October 22, 2025 and initiated October 9, 2025. Recalling firm: STAQ Pharma, Inc.; Status: Ongoing; Lot: Lot #: 25104595A, Expiry: 27DEC2025. Class III means the product is not likely to cause adverse health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labeling: Incorrect or Missing Lot and/or Exp Date

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
STAQ Pharma, Inc.
Distributor
Nationwide in the U.S.
Lot
Lot #: 25104595A, Expiry: 27DEC2025.
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Hydromorphone HCL PF, 10mg/50 mL (0.2mg/mL) in NACL, Injection for IV use, 50 mL Syringe, STAQ Pharma Inc., 14135 E 42nd Ave, Denver, Colorado, NDC 73177-0104-05. recalled?

Yes. FDA published recall D-0023-2026 on October 22, 2025. Reported hazard: Labeling: Incorrect or Missing Lot and/or Exp Date

What should I do if I have this product?

Voluntary: Firm initiated · Letter